Commercial multileaf collimator (MLC) systems can employ leaves with rounded ends. Treatment planning beam modelling should consider the effects of transmission through rounded leaf ends to provide accurate dosimetry for IMRT treatments delivered with segmented MLC. We determined that an MLC leaf gap reduction of 1.4 mm is required to obtain an agreement between calculated and measured profile 50% dose points. A head and neck dosimetry phantom, supplied by the Radiological Physics Center (RPC), was planned and irradiated as a necessary credentialing requirement for the RTOG H-0022 protocol. The agreement between the RPC TLD measurements and treatment planning calculations was within experimental error for the primary and secondary planning target volumes (PTVs); however, the calculated mean dose for the critical structure was approximately 9% lower than the RPC TLD measurements. RPC radiochromic film profile measurements also indicated significant discrepancies (>5%) with calculated values especially in the high dose gradient region in the vicinity of the critical structure. These results substantiate our own in-house phantom measurements, performed with the same IMRT fields as for the RPC phantom experiment, using Kodak EDR2 film to measure absolute dose. Our results indicate a maximum underestimate of calculated dose of 12% with no leaf gap reduction. The discrepancy between measured and calculated phantom values is reduced to +/- 5% when a leaf gap reduction of 1.4 mm is used. A further improvement in the accuracy of dose calculation is not possible without a more accurate modelling of the leaf end transmission by the planning system. In the absence of published dosimetric criteria for IMRT our results stress the need for stringent in-house dosimetric QA and validation for IMRT treatments. We found the dosimetric validation service provided by the RPC to be a valuable component of our IMRT validation efforts.

In this work, an amorphous silicon electronic portal imaging device (a-Si EPID) dose prediction model based on the energy fluence model of the Pinnacle treatment planning system Version 7 (Philips Medical Systems, Madison, WI) is developed. An energy fluence matrix at very high resolution (< 1 mm) is used to incorporate multileaf collimator (MLC) leaf effects in the predicted EPID images. The primary dose deposited in the EPID is calculated from the energy fluence using experimentally derived radially dependent EPID interaction coefficients. Separate coefficients are used for the open beam energy fluence component and the component of the energy fluence transmitted through closed MLC leaves to each EPID pixel. A spatially invariant EPID dose deposition kernel that describes both radiative dose deposition, central axis EPID backscatter, and optical glare is convolved with the primary dose. The kernel is further optimized to give accurate EPID penumbra prediction and EPID scatter factor with changing MLC field size. An EPID calibration method was developed to reduce the effect of nonuniform backscatter from the support arm (E-arm) in a calibrated EPID image. This method removes the backscatter component from the pixel sensitivity (flood field) correction matrix retaining only field-specific backscatter in the images. The model was compared to EPID images for jaw and MLC defined open fields and eight head and neck intensity modulated radiotherapy (IMRT) fields. For the head and neck IMRT fields with 2%, 2 mm criteria 97.6 +/- 0.6% (mean +/- 1 standard deviation) of points passed with a gamma index less than 1, and for 3%, 3 mm 99.4 +/- 0.4% of points were within the criteria. For these fields, the 2%, 2 mm pass score reduced to 96.0 +/- 1.5% when backscatter was present in the pixel sensitivity correction matrix. The model incorporates the effect of MLC leaf transmission, EPID response to open and MLC leakage dose components, and accurately predicts EPID images of IMRT fields. Removing the backscatter component of the pixel sensitivity matrix correction reduces the effect of nonuniform E-arm backscatter.

A new Pinnacle 3D treatment‐planning system software release has recently become available (v7.4, Philips Radiation Oncology Systems, Milpitas, CA), which supports modeling of rounded multileaf collimator (MLC) leaf ends; it also includes a number of other software enhancements intended to improve the overall dose calculation accuracy. In this report, we provide a general discussion of the dose calculation algorithm and new beam‐modeling parameters. The accuracy of a diode dosimeter was established for measurement of MLC‐shaped beam profiles required by the new software version by comparison with film and ion chamber measurements in various regions of the field. The results suggest that a suitable diode or other small volume dosimeter with appropriate energy sensitivity should be used to obtain profiles for commissioning the planning system. Film should be used with caution, especially for larger field profile measurements. The dose calculation algorithm and modeling parameters chosen were validated through various test field measurements including a bar pattern, a strip pattern, and a clinical head and neck IMRT field. For the bar and strip patterns, the agreement between Pinnacle calculations and diode measurements was generally very good. These tests were helpful in establishing the new model parameter values, especially tongue‐and‐groove width, additional interleaf leakage, rounded leaf tip radius, and MLC transmission. For the clinical head and neck field, the comparison between Pinnacle and film measurements showed regions of approximately 2 cGy under‐ or overdose. However, the Pinnacle calculations agreed with diode measurements at all points to within 1 cGy or 1% of the maximum dose for the field (67 cGy). The greatest discrepancy between film and diode measurements for the clinical field (maximum of 2.8%) occurred in low‐dose regions in the central part of the field. The disagreement may be due to the overresponse of film to scattered radiation in the low‐dose regions, which have significant shielding by the MLCs.PACS numbers: 87.53.Bn, 87.53.Dq

BackgroundFiducial markers and daily electronic portal imaging (EPI) can reduce the risk of geographic miss in prostate cancer radiotherapy. The purpose of this study was to estimate CTV to PTV margin requirements, without and with the use of this image guidance strategy.Methods46 patients underwent placement of 3 radio-opaque fiducial markers prior to prostate RT. Daily pre-treatment EPIs were taken, and isocenter placement errors were corrected if they were ≥ 3 mm along the left-right or superior-inferior axes, and/or ≥ 2 mm along the anterior-posterior axis. During-treatment EPIs were then obtained to estimate intra-fraction motion.ResultsWithout image guidance, margins of 0.57 cm, 0.79 cm and 0.77 cm, along the left-right, superior-inferior and anterior-posterior axes respectively, are required to give 95% probability of complete CTV coverage each day. With the above image guidance strategy, these margins can be reduced to 0.36 cm, 0.37 cm and 0.37 cm respectively. Correction of all isocenter placement errors, regardless of size, would permit minimal additional reduction in margins.ConclusionsImage guidance, using implanted fiducial markers and daily EPI, permits the use of narrower PTV margins without compromising coverage of the target, in the radiotherapy of prostate cancer.